Pharmaceutical Approvals Monthly

Information on FDA decisions, clinical trial updates and new product strategies

Pharmaceutical Approvals Monthly provides in-depth coverage of U.S. drug approvals, including a thorough tabulation of FDA approval actions broken down by original, supplemental and ANDA classifications. This specialized monthly delves behind the scenes and into the pre-approval review process on important new drugs to explore the issues raised about a drug during its regulatory review at FDA.

Managing Editor: Mary Jo Laffler

View full editorial board

Imprint: Elsevier Business Intelligence

ISSN: 1530-6232


advert image